U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07934550) titled 'Prospective, Multi-Center Observational Registry of Melanoma CP-GEP and Clinical Outcomes' on Nov. 05.
Brief Summary: The purpose of the registry is to understand how Merlin CP-GEP testing is used in routine care and whether the test result is associated with clinical decision-making in people with melanoma who are 65 years of age or older. The study will also collect available information about treatment decisions and clinical outcomes over time.
Study Start Date: Jan., 2027
Study Type: OBSERVATIONAL
Condition:
Melanoma (Skin Cancer)
Gene Expression Profiling
Recruitment Status: NOT_YET_RECRUITING
Sponsor: SkylineDx
Disclaim...